ciprofloxacin and reserpine

ciprofloxacin has been researched along with reserpine in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (13.64)	18.2507
2000's	16 (36.36)	29.6817
2010's	22 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arpin, C; Ba, BB; Caignard, DH; Forfar-Bares, I; Grellet, J; Guillon, J; Jarry, C; Moreau, S; Quentin, C; Vidaillac, C	1
Elkins, CA; Mullis, LB	1
Brown, DL; Deziel, MR; Drusano, GL; Kulawy, RW; Liu, W; Louie, A	1
German, N; Kaatz, GW; Kerns, RJ; Wei, P	1
Andotra, SS; Khan, IA; Koul, S; Kumar, A; Qazi, GN; Raja, AF; Reddy, MV; Sangwan, PL; Thota, N	1
Brandini, D; Fravolini, A; Kaatz, GW; Rossolini, GM; Sabatini, S	1
Kalia, NP; Khan, IA; Koul, JL; Koul, S; Kumar, A; Qazi, GN; Reddy, MV; Sangwan, PL; Thota, N	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Brincat, JP; Carosati, E; Dimovska, M; Fravolini, A; Kaatz, GW; Massari, S; Pieroni, M; Sabatini, S	1
Kalia, NP; Khan, IA; Koul, JL; Koul, S; Kumar, A; Reddy, MV; Sangwan, PL; Thota, N	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Chen, X; Lin, X; Skolnik, S; Wang, J	1
Cecchetti, V; Gosetto, F; Kaatz, GW; Manfroni, G; Patel, D; Sabatini, S; Tabarrini, O	1
Brincat, JP; Carosati, E; Cecchetti, V; Gosetto, F; Iraci, N; Kaatz, GW; Manfroni, G; Sabatini, S; Serritella, S; Tabarrini, O; Villarini, M	1
Christensen, SB; Holler, JG; Mølgaard, P; Olsen, CE; Slotved, HC	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Barreca, ML; Cecchetti, V; Dimovska, M; Gosetto, F; Iraci, N; Kaatz, GW; Manfroni, G; Massari, S; Sabatini, S; Sancineto, L; Tabarrini, O	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bouillon, A; Cresteil, T; Fontaine, F; Hequet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS	2
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barreca, ML; Cannalire, R; Cecchetti, V; Felicetti, T; Kaatz, GW; Manfroni, G; Massari, S; Nizi, MG; Sabatini, S; Schindler, BD; Tabarrini, O	1
Barreca, ML; Cannalire, R; Cecchetti, V; Felicetti, T; Kaatz, GW; Kieć-Kononowicz, K; Latacz, G; Lubelska, A; Manfroni, G; Massari, S; Pietrella, D; Sabatini, S; Schindler, BD; Tabarrini, O	1
Hill, SL; Johnson, M; Piddock, LJ; Ricci, V	1
Engler, B; Fluit, AC; Hadding, U; Heinz, HP; Hofmann, B; Jones, ME; Lückefahr, M; Schmitz, FJ; Verhoef, J	1
Markham, PN	1
Gootz, TD; Haskell, SL; Kaczmarek, FS; Maurice, AE; Zaniewski, RP	1
Johnson, ME; Klyachko, K; Markham, PN; Neyfakh, AA; Westhaus, E	1
Brisse, S; Fluit, AC; Köhrer, K; Milatovic, D; Schmitz, FJ; Verhoef, J	1
Jiminez de Anta, MT; Ribera, A; Ruiz, J; Vila, J	1
Gustafson, JE; Kaatz, GW; Price, CT	1
Duan, DQ; Lin, YG; Xu, F	1
Arcesi, F; Bellinzoni, M; De Rossi, E; Guglierame, P; Pasca, MR; Riccardi, G	1
Daporta, MT; García-Rodríguez, JA; Guirao, GY; Hernández, MS; Muñoz Bellido, JL	1
Campion, JJ; Evans, ME; McNamara, PJ	1
Johnson, MM; Marrer, E; Page, MG; Piddock, LJ; Satoh, AT; Schad, K	1
Garvey, MI; Piddock, LJ	1
Cetinkaya, E; Coban, AY; Durupinar, B	1
Duesberg, CB; Fuehner, T; Klugman, KP; Makarewicz, O; Michaylov, N; Pletz, MW; Schumacher, U; van der Linden, M; Welte, T	1
Chen, YS; Huang, SP; Huang, TS; Kunin, CM; Lee, SS; Syu, WJ; Wang, HM; Yan, BS	1
Cattoir, V; Courvalin, P; Galimand, M; Guérin, F; Tuambilangana, F	1
Bucar, F; Klančnik, A; Kovač, J; Možina, SS; Šimunović, K; Wu, Z; Zhang, Q	1
Dey, D; Ghosh, S; Hazra, B; Ray, R	1
Iqbal, M; Ismat, F; Mahboob, S; Mirza, O; Rahman, M; Rauf, W; Sana, M; Shaheen, A; Tariq, A	1

Reviews

1 review(s) available for ciprofloxacin and reserpine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

43 other study(ies) available for ciprofloxacin and reserpine

Article	Year
Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Indicators and Reagents; Kinetics; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Norfloxacin; Omeprazole; Staphylococcus aureus; Structure-Activity Relationship	2007
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding, Competitive; Carrier Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Indicators and Reagents; Microbial Sensitivity Tests; Progesterone; Steroids	2007
In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple; Ethidium; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Reserpine; Streptococcus pneumoniae	2007
Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps. European journal of medicinal chemistry, 2008, Volume: 43, Issue:11 Topics: Carrier Proteins; Fluoroquinolones; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity	2008
Citral derived amides as potent bacterial NorA efflux pump inhibitors. Bioorganic & medicinal chemistry, 2008, Jul-01, Volume: 16, Issue:13 Topics: Amides; Bacterial Proteins; Ciprofloxacin; Molecular Structure; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Structure-Activity Relationship	2008
From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Phenothiazines; Staphylococcus aureus; Thiazines	2008
Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors. Bioorganic & medicinal chemistry, 2008, Nov-15, Volume: 16, Issue:22 Topics: Alkaloids; Anti-Bacterial Agents; Bacterial Proteins; Benzodioxoles; Ciprofloxacin; Enzyme Inhibitors; Ethidium; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Nucleic Acid Synthesis Inhibitors; Piperidines; Polyunsaturated Alkamides; Staphylococcus aureus	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps. Journal of medicinal chemistry, 2010, Jun-10, Volume: 53, Issue:11 Topics: Aminoquinolines; Anti-Bacterial Agents; Drug Resistance, Multiple; Esters; Ethidium; Genes, MDR; Microbial Sensitivity Tests; Staphylococcus aureus; Structure-Activity Relationship	2010
Substituted dihydronaphthalenes as efflux pump inhibitors of Staphylococcus aureus. European journal of medicinal chemistry, 2010, Volume: 45, Issue:9 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Synergism; Membrane Transport Proteins; Microbial Sensitivity Tests; Naphthalenes; Staphylococcus aureus; Structure-Activity Relationship	2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity	2011
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. Journal of medicinal chemistry, 2011, Aug-25, Volume: 54, Issue:16 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Synergism; Flavones; Hydroxyquinolines; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Multidrug Resistance-Associated Proteins; Mutation; Species Specificity; Staphylococcus aureus; Structure-Activity Relationship	2011
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors. Journal of medicinal chemistry, 2012, Apr-12, Volume: 55, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Proteins; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Resistance, Multiple, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Models, Molecular; Multidrug Resistance-Associated Proteins; Pyrazoles; Small Molecule Libraries; Staphylococcus aureus; Structure-Activity Relationship; Sulfonamides; Thiazines	2012
Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles. Bioorganic & medicinal chemistry, 2012, Jul-15, Volume: 20, Issue:14 Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Chalcone; Ciprofloxacin; Drug Synergism; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance. Journal of medicinal chemistry, 2013, Jun-27, Volume: 56, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Proteins; Chemistry Techniques, Synthetic; Computer-Aided Design; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Inhibitory Concentration 50; Ligands; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Multidrug Resistance-Associated Proteins; Quinolines; Staphylococcus aureus; Structure-Activity Relationship	2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump. Journal of medicinal chemistry, 2014, Mar-27, Volume: 57, Issue:6 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Boronic Acids; Cell Survival; Ciprofloxacin; Culture Media; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; KB Cells; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Structure-Activity Relationship	2014
Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives. European journal of medicinal chemistry, 2015, May-05, Volume: 95 Topics: Anti-Bacterial Agents; Bacterial Proteins; Boronic Acids; Ciprofloxacin; Humans; KB Cells; Multidrug Resistance-Associated Proteins; Pyridines; Staphylococcal Infections; Staphylococcus aureus	2015
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position. European journal of medicinal chemistry, 2018, Jul-15, Volume: 155 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinolines; Staphylococcus aureus; Structure-Activity Relationship	2018
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction. Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17 Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Tissue Distribution	2018
Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Haemophilus; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Reserpine; Respiratory Tract Infections; Streptococcus pneumoniae	1998
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Genes, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Polymerase Chain Reaction; Quinolines; Reserpine; Staphylococcal Infections; Staphylococcus aureus	1998
Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:4 Topics: Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Microbial Sensitivity Tests; Reserpine; Streptococcus pneumoniae	1999
Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8 Topics: Adrenergic Uptake Inhibitors; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; Drug Interactions; Drug Resistance, Microbial; Enzyme Inhibitors; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Reserpine; Staphylococcus aureus; Topoisomerase II Inhibitors	1999
Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:10 Topics: Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Ciprofloxacin; Drug Interactions; Drug Resistance, Microbial; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Reserpine; Staphylococcus aureus	1999
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS immunology and medical microbiology, 1999, Volume: 26, Issue:3-4 Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Reserpine; Staphylococcal Infections; Staphylococcus aureus	1999
Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:4 Topics: Acinetobacter; Anti-Infective Agents; Ciprofloxacin; Dipeptides; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Reserpine	2002
The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus. International journal of antimicrobial agents, 2002, Volume: 20, Issue:3 Topics: Bacterial Proteins; Ciprofloxacin; Drug Interactions; Drug Resistance, Bacterial; Ethidium; Fusidic Acid; Multidrug Resistance-Associated Proteins; Mutation; Proton-Motive Force; Reserpine; Sodium Salicylate; Staphylococcus aureus; Time Factors	2002
[A study on the active efflux mechanism in Staphylococcus aureus resistant to quinolone]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2004, Volume: 27, Issue:6 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quinolones; Reserpine; Staphylococcus aureus	2004
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8 Topics: Anti-Infective Agents; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Ciprofloxacin; DNA Primers; Drug Resistance; Energy Metabolism; Fluoroquinolones; Gene Expression Regulation, Bacterial; Hydrazones; Mycobacterium smegmatis; Mycobacterium tuberculosis; Operon; Reserpine; Verapamil	2004
In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae. International journal of antimicrobial agents, 2004, Volume: 24, Issue:2 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Reserpine; Streptococcus pneumoniae	2004
Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; DNA Gyrase; Drug Resistance, Bacterial; Kinetics; Methicillin Resistance; Microbial Sensitivity Tests; Reserpine; Staphylococcus aureus	2004
Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:2 Topics: Anti-Infective Agents; ATP-Binding Cassette Transporters; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Norfloxacin; Phenotype; Reserpine; RNA, Messenger; Streptococcus pneumoniae	2006
The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: ATP-Binding Cassette Transporters; Bacterial Proteins; Biological Transport; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethidium; Gene Order; Mutation; Polymerase Chain Reaction; Protein Isoforms; Reserpine; Streptococcus pneumoniae; Vanadates	2008
[Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus]. Mikrobiyoloji bulteni, 2008, Volume: 42, Issue:4 Topics: Acinetobacter baumannii; Anti-Infective Agents; Ciprofloxacin; Dipeptides; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Reserpine; Staphylococcus aureus	2008
Antihypertensives suppress the emergence of fluoroquinolone-resistant mutants in pneumococci: an in vitro study. International journal of medical microbiology : IJMM, 2013, Volume: 303, Issue:4 Topics: Anti-Bacterial Agents; Antihypertensive Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Mutation Rate; Pneumococcal Infections; Reserpine; Sequence Analysis, DNA; Streptococcus pneumoniae; Verapamil	2013
Inhibition of the Mycobacterium tuberculosis reserpine-sensitive efflux pump augments intracellular concentrations of ciprofloxacin and enhances susceptibility of some clinical isolates. Journal of the Formosan Medical Association = Taiwan yi zhi, 2013, Volume: 112, Issue:12 Topics: Adrenergic Uptake Inhibitors; Anti-Bacterial Agents; Cell Membrane Permeability; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Reserpine	2013
Overexpression of the novel MATE fluoroquinolone efflux pump FepA in Listeria monocytogenes is driven by inactivation of its local repressor FepR. PloS one, 2014, Volume: 9, Issue:9 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Listeria monocytogenes; Norfloxacin; Reserpine	2014
Antibiotic resistance modulation and modes of action of (-)-α-pinene in Campylobacter jejuni. PloS one, 2015, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Bicyclic Monoterpenes; Campylobacter jejuni; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Membrane Permeability; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Metabolic Networks and Pathways; Microbial Sensitivity Tests; Monoterpenes; Mutagenesis, Insertional; Reserpine; Transcriptome	2015
Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of β-Lactamase-producing Klebsiella pneumoniae. Phytotherapy research : PTR, 2016, Volume: 30, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Caffeic Acids; Catechin; Ciprofloxacin; Drug Synergism; Ellagic Acid; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phytochemicals; Polyphenols; Quercetin; Reserpine; Tetracycline	2016
Restraining the multidrug efflux transporter STY4874 of Salmonella Typhi by reserpine and plant extracts. Letters in applied microbiology, 2019, Volume: 69, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Monosaccharide Transport Proteins; Plant Extracts; Reserpine; Salmonella typhi; Silybum marianum	2019